S&P 500   3,636.43 (+1.64%)
DOW   30,094.95 (+1.70%)
QQQ   293.76 (+1.16%)
AAPL   114.85 (+0.88%)
MSFT   213.70 (+1.71%)
FB   274.41 (+2.23%)
GOOGL   1,756.66 (+1.68%)
AMZN   3,128.85 (+0.98%)
TSLA   546.68 (+4.76%)
NVDA   519.64 (-1.13%)
BABA   276.88 (+2.51%)
CGC   26.84 (+8.58%)
GE   10.52 (+4.47%)
MU   63.39 (-1.23%)
AMD   84.91 (-0.47%)
T   29.28 (+2.31%)
NIO   52.78 (-4.69%)
F   9.43 (+6.43%)
ACB   8.94 (+24.51%)
NFLX   480.46 (+0.81%)
GILD   60.81 (+1.54%)
BA   220.80 (+4.38%)
DIS   151.26 (+3.62%)
S&P 500   3,636.43 (+1.64%)
DOW   30,094.95 (+1.70%)
QQQ   293.76 (+1.16%)
AAPL   114.85 (+0.88%)
MSFT   213.70 (+1.71%)
FB   274.41 (+2.23%)
GOOGL   1,756.66 (+1.68%)
AMZN   3,128.85 (+0.98%)
TSLA   546.68 (+4.76%)
NVDA   519.64 (-1.13%)
BABA   276.88 (+2.51%)
CGC   26.84 (+8.58%)
GE   10.52 (+4.47%)
MU   63.39 (-1.23%)
AMD   84.91 (-0.47%)
T   29.28 (+2.31%)
NIO   52.78 (-4.69%)
F   9.43 (+6.43%)
ACB   8.94 (+24.51%)
NFLX   480.46 (+0.81%)
GILD   60.81 (+1.54%)
BA   220.80 (+4.38%)
DIS   151.26 (+3.62%)
S&P 500   3,636.43 (+1.64%)
DOW   30,094.95 (+1.70%)
QQQ   293.76 (+1.16%)
AAPL   114.85 (+0.88%)
MSFT   213.70 (+1.71%)
FB   274.41 (+2.23%)
GOOGL   1,756.66 (+1.68%)
AMZN   3,128.85 (+0.98%)
TSLA   546.68 (+4.76%)
NVDA   519.64 (-1.13%)
BABA   276.88 (+2.51%)
CGC   26.84 (+8.58%)
GE   10.52 (+4.47%)
MU   63.39 (-1.23%)
AMD   84.91 (-0.47%)
T   29.28 (+2.31%)
NIO   52.78 (-4.69%)
F   9.43 (+6.43%)
ACB   8.94 (+24.51%)
NFLX   480.46 (+0.81%)
GILD   60.81 (+1.54%)
BA   220.80 (+4.38%)
DIS   151.26 (+3.62%)
S&P 500   3,636.43 (+1.64%)
DOW   30,094.95 (+1.70%)
QQQ   293.76 (+1.16%)
AAPL   114.85 (+0.88%)
MSFT   213.70 (+1.71%)
FB   274.41 (+2.23%)
GOOGL   1,756.66 (+1.68%)
AMZN   3,128.85 (+0.98%)
TSLA   546.68 (+4.76%)
NVDA   519.64 (-1.13%)
BABA   276.88 (+2.51%)
CGC   26.84 (+8.58%)
GE   10.52 (+4.47%)
MU   63.39 (-1.23%)
AMD   84.91 (-0.47%)
T   29.28 (+2.31%)
NIO   52.78 (-4.69%)
F   9.43 (+6.43%)
ACB   8.94 (+24.51%)
NFLX   480.46 (+0.81%)
GILD   60.81 (+1.54%)
BA   220.80 (+4.38%)
DIS   151.26 (+3.62%)
Log in
OTCMKTS:MAMP

Medamerica Properties Stock Forecast, Price & News

$3.07
+0.32 (+11.64 %)
(As of 12/27/2019)
Add
Compare
Today's Range
$2.75
Now: $3.07
$3.07
50-Day Range
$3.07
MA: $3.07
$3.07
52-Week Range
$1.90
Now: $3.07
$6.00
Volume300 shs
Average Volume276 shs
Market Capitalization$8.01 million
P/E RatioN/A
Dividend YieldN/A
Beta-2.54
MedAmerica Properties Inc., a real estate management company, focuses on investing in commercial real estate properties in the United States. It focuses to acquire medical office buildings. The company was formerly known as Banyan Rail Services Inc. and changed its name to MedAmerica Properties Inc. in June 2017. MedAmerica Properties Inc. was founded in 1985 and is based in Boca Raton, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Sanitary services
Sub-IndustryN/A
SectorFinance
Current SymbolOTCMKTS:MAMP
Previous SymbolOTCMKTS:BARA
CUSIPN/A
Phone561-617-8050
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.01 per share

Profitability

Net Income$-600,000.00

Miscellaneous

Market Cap$8.01 million
Next Earnings DateN/A
OptionableNot Optionable
$3.07
+0.32 (+11.64 %)
(As of 12/27/2019)
30 days | 90 days | 365 days | Advanced Chart

Receive MAMP News and Ratings via Email

Sign-up to receive the latest news and ratings for MAMP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Medamerica Properties (OTCMKTS:MAMP) Frequently Asked Questions

How has Medamerica Properties' stock price been impacted by Coronavirus?

Medamerica Properties' stock was trading at $3.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MAMP shares have increased by 0.0% and is now trading at $3.07.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Medamerica Properties?

Wall Street analysts have given Medamerica Properties a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Medamerica Properties wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Medamerica Properties' key competitors?

What other stocks do shareholders of Medamerica Properties own?

Who are Medamerica Properties' key executives?

Medamerica Properties' management team includes the following people:
  • Mr. Joseph C. Bencivenga, Pres , CEO & Director (Age 60)
  • Ms. Patricia K. Sheridan, Chief Financial Officer (Age 57)
  • Mr. Robert I. Schellig Jr., Sr. VP & Gen. Counsel (Age 75)
  • Ms. Natalie Ann Macey, VP of Sales & Marketing
  • Christopher J. Hubbert, Sec.

What is Medamerica Properties' stock symbol?

Medamerica Properties trades on the OTCMKTS under the ticker symbol "MAMP."

How do I buy shares of Medamerica Properties?

Shares of MAMP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medamerica Properties' stock price today?

One share of MAMP stock can currently be purchased for approximately $3.07.

How big of a company is Medamerica Properties?

Medamerica Properties has a market capitalization of $8.01 million.

What is Medamerica Properties' official website?

The official website for Medamerica Properties is www.medamericaproperties.com.

How can I contact Medamerica Properties?

Medamerica Properties' mailing address is Boca Center Tower 1 5200 Town Center Circle Suite 550, BOCA RATON FL, 33486. The company can be reached via phone at 561-617-8050 or via email at [email protected]

This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.